197 related articles for article (PubMed ID: 34079708)
1. Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer).
Mazzei MA; Di Giacomo L; Bagnacci G; Nardone V; Gentili F; Lucii G; Tini P; Marrelli D; Morgagni P; Mura G; Baiocchi GL; Pittiani F; Volterrani L; Roviello F
Quant Imaging Med Surg; 2021 Jun; 11(6):2376-2387. PubMed ID: 34079708
[TBL] [Abstract][Full Text] [Related]
2. Delta computed tomography radiomics features-based nomogram predicts long-term efficacy after neoadjuvant chemotherapy in advanced gastric cancer.
Shen LL; Zheng HL; Ding FH; Lu J; Chen QY; Xu BB; Xue Z; Lin J; Huang CM; Zheng CH
Radiol Med; 2023 Apr; 128(4):402-414. PubMed ID: 36940007
[TBL] [Abstract][Full Text] [Related]
3. A CT-based deep learning radiomics nomogram for predicting the response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer: A multicenter cohort study.
Cui Y; Zhang J; Li Z; Wei K; Lei Y; Ren J; Wu L; Shi Z; Meng X; Yang X; Gao X
EClinicalMedicine; 2022 Apr; 46():101348. PubMed ID: 35340629
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Computed Tomography-Based Radiomics Signature to Predict Response to Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer.
Wang W; Peng Y; Feng X; Zhao Y; Seeruttun SR; Zhang J; Cheng Z; Li Y; Liu Z; Zhou Z
JAMA Netw Open; 2021 Aug; 4(8):e2121143. PubMed ID: 34410397
[TBL] [Abstract][Full Text] [Related]
5. Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.
Nardone V; Reginelli A; Grassi R; Vacca G; Giacobbe G; Angrisani A; Clemente A; Danti G; Correale P; Carbone SF; Pirtoli L; Bianchi L; Vanzulli A; Guida C; Grassi R; Cappabianca S
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740669
[TBL] [Abstract][Full Text] [Related]
6. CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy.
Chen Y; Xu W; Li YL; Liu W; Sah BK; Wang L; Xu Z; Wels M; Zheng Y; Yan M; Zhang H; Ma Q; Zhu Z; Li C
Front Oncol; 2022; 12():758863. PubMed ID: 35280802
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and prognostic value of delta radiomics on dual-energy computed tomography for gastric cancer with neoadjuvant chemotherapy: a preliminary study.
Wang L; Chen Y; Tan J; Ge Y; Xu Z; Wels M; Pan Z
Acta Radiol; 2023 Apr; 64(4):1311-1321. PubMed ID: 36062762
[TBL] [Abstract][Full Text] [Related]
8. CT-based radiomics analysis in the prediction of response to neoadjuvant chemotherapy in locally advanced gastric cancer: A dual-center study.
Song R; Cui Y; Ren J; Zhang J; Yang Z; Li D; Li Z; Yang X
Radiother Oncol; 2022 Jun; 171():155-163. PubMed ID: 35490846
[TBL] [Abstract][Full Text] [Related]
9. Can low-dose CT perfusion imaging accurately assess response of advanced gastric cancer with neoadjuvant chemotherapy?
Sun ZQ; Yan G; Ge YX; Li J; Jin LF; Xie ZH; Zhao P
J Xray Sci Technol; 2017; 25(6):981-991. PubMed ID: 28697579
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of CT volumetry for primary gastric lesions in predicting pathologic response to neoadjuvant chemotherapy in advanced gastric cancer.
Lee SM; Kim SH; Lee JM; Im SA; Bang YJ; Kim WH; Kim MA; Yang HK; Lee HJ; Kang WJ; Han JK; Choi BI
Abdom Imaging; 2009 Jul; 34(4):430-40. PubMed ID: 18546037
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment Contrast-Enhanced Computed Tomography Radiomics for Prediction of Pathological Regression Following Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer: A Preliminary Multicenter Study.
Xie K; Cui Y; Zhang D; He W; He Y; Gao D; Zhang Z; Dong X; Yang G; Dai Y; Li Z
Front Oncol; 2021; 11():770758. PubMed ID: 35070974
[TBL] [Abstract][Full Text] [Related]
12. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
[TBL] [Abstract][Full Text] [Related]
13. The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer.
Wei C; He Y; Luo M; Chen G; Nie R; Chen X; Zhou Z; Chen Y
BMC Cancer; 2023 Nov; 23(1):1157. PubMed ID: 38012547
[TBL] [Abstract][Full Text] [Related]
14. Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study.
Mazzei MA; Bagnacci G; Gentili F; Nigri A; Pelini V; Vindigni C; Mazzei FG; Baiocchi GL; Pittiani F; Morgagni P; Petrella E; Mura G; Verdelli B; Bencivenga M; Giacopuzzi S; Marrelli D; Roviello F; Volterrani L
Gastroenterol Res Pract; 2018; 2018():1794524. PubMed ID: 29736166
[TBL] [Abstract][Full Text] [Related]
15. [Value of double contrast-enhanced ultrasound QontraXt three-dimensional pseudocolor quantitative analysis to therapeutic effect evaluation of preoperative neoadjuvant chemotherapy in advanced gastric cancer patients].
Yan CX; Huang PT; Shentu WH; Lin ZM; Li J; Zhang Y; Xu JH; Jin XL
Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):857-863. PubMed ID: 30481939
[No Abstract] [Full Text] [Related]
16. Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab.
Nardone V; Tini P; Pastina P; Botta C; Reginelli A; Carbone SF; Giannicola R; Calabrese G; Tebala C; Guida C; Giudice A; Barbieri V; Tassone P; Tagliaferri P; Cappabianca S; Capasso R; Luce A; Caraglia M; Mazzei MA; Pirtoli L; Correale P
Oncol Lett; 2020 Feb; 19(2):1559-1566. PubMed ID: 31966081
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography-based radiomics for prediction of neoadjuvant chemotherapy outcomes in locally advanced gastric cancer: A pilot study.
Li Z; Zhang D; Dai Y; Dong J; Wu L; Li Y; Cheng Z; Ding Y; Liu Z
Chin J Cancer Res; 2018 Aug; 30(4):406-414. PubMed ID: 30210220
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of dual-energy CT derived radiomics signatures in predicting outcomes in patients with advanced gastric cancer after neoadjuvant chemotherapy.
Chen Y; Yuan F; Wang L; Li E; Xu Z; Wels M; Yao W; Zhang H
Eur J Surg Oncol; 2022 Feb; 48(2):339-347. PubMed ID: 34304951
[TBL] [Abstract][Full Text] [Related]
20. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
